Zur Fortbildung empfohlene Übersichtsarbeiten

Effects of perinatal, late fetal, and early embryonic insults on the cardiovascular phenotype in experimental animal models and humans
Theo Arthur Meister, Emrush Rexhaj, Stefano Flavio Rimaldi, Urs Scherrer, Claudio Sartori (VASA 6/16)
Clinical relevance of cerebral blood pressure - a critical review
Michael Kostapanos, Carmel M. McEniery, Ian B. Wilkinson (VASA 6/16)
Vascular puncture site complications - diagnosis, therapy and prognosis
Wolfgang Mlekusch, Irene Mlekusch, Schila Sabeti-Sandor (VASA 6/16)
Nailfold capillaroscopy microscopy – an interdisciplinary appraisal
Peter Frank Klein-Weigel, Cord Sunderkötter, Oliver Sander (VASA 5/16)
Angioplasty wioth drug coated balloons for the treatment of infrainguinal peripheral artery disease
Martin Werner (VASA 5/16)
Endovascular treatment of ischaemic stroke patients – new evidence and old challenges
Johannes Gerber, Volker Puetz, Ulf Bodechtel, Hagen Kitzler, Ruediger von Kummer, Jennifer Linn (VASA 4/16)
Pelvic congestion syndrome and left renal compression syndrome – clinical features and therapeutic approaches
Christina Jeanneret, Konstantin Beier Alexander von Weymarn, Jürg Traber (VASA 4/16)
Management of lymphedema
Ahmet Yüksel, Orçun Gürbüz, Yusuf Velioğlu, Gencehan Kumtepe, Sefa Şenol (VASA 4/16)
Chronic thromboembolic pulmonary hypertension – a diagnostic and therapeutic update
Hans Stricker (VASA 3/16)
Raynaud’s phenomenon and digital ischaemia – pharmacologic approach and alternative treatment options
Birgit Linnemann, Matthias Erbe (VASA 3/16)
Treatment of acute lower limb ischemia
Aleksander Lukasiewicz (VASA 3/16)
Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH)
Birgit Linnemann, Rupert Bauersachs, Hannelore Rott, Susan Halimeh, Rainer Zotz, Andrea Gerhardt, Barbara Boddenberg-Pätzold, Bettina Toth, Ute Scholz (VASA 2/16)
The association between body mass index and abdominal aortic aneurysm growth: a systematic review
Hisato Takagi, Takuya Umemoto (VASA 2/16)
Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
Lindsay Brammen, Sabine Steiner, Robert Berent, Helmut Sinzinger (VASA 2/16)
Gender differences in patients with carotid stenosis
Konstanze Stoberock, Eike Sebastian Debus, Atlihan Gülsen, Daum Günther, Axel Larena-Avellaneda, Sandra Eifert, Sabine Wipper (VASA 1/16)
Inflammatory diseases of the aorta
Ludwig Caspary (VASA 1/16)
Exercise rehabilitation for peripheral artery disease: An exercise physiology perspective with special emphasis on the emerging trend of home-based exercise A. W. Gardner (VASA 6/15)
Markers of preclinical atherosclerosis and their clinical relevance
P. Poredos, M. K. Jezovnik (VASA 5/15)
Raynaud's phanomenon - assesment and differential diagnoses / Raynaud-Phänomen - Diagnostik und Differenzialdiagnose
B. Linnemann, M. Erbe (VASA 3/15)
Hypothenar hammer syndrome / Hypothenar-Hammer-Syndrom
A. Schröttle, M. Czihal, C. Lottspeich, R. Kuhlencordt, D. Nowak, U. Hoffmann (VASA 3/15)
Integrative therapy in patients with intermittent claudication / Integrative Therapie bei Patienten mit Claudicatio intermittens
E. Minar (VASA 2/15)
Combinded and complex vascular malformations / Kombinierte und komplexe vaskuläre Malformationen
R. K. Clemens, T. Pfannenmatter, T. O. Meier, A. I. Alomari, B. Amann-Vesti
Vascular malformations revisited / Gefäßfehlbildungen im Überblick
Robert K. Clemens, Thomas Pfammatter, Thomas O. Meier, Ahmad I. Alomari und Beatrice R. Amann-Vesti (VASA 1/15)
Carotid artery disease after head and neck radiotherapy / Strahlenbedingtes Gefäßwandveränderungen der Arteria carotis
Christoph Thalhammer, Marc Husmann, Christoph Glanzmann, Gabriela Studer und Beatrice R. Amann-Vesti (VASA 1/15)
Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications
L. Pernomian, L. Pernomian, C. Baraldi, A. Restini (VASA 6/14)
Asymptomatic peripheral artery disease and antiplatelet management
V. Raparelli, M. Proietti, L. Napoleone, T. Bucci, G. Talerico, F.S. Pignataro und S.Basili (VASA 5/14)
Lower extremity vasculitis in giant cell arteritis: Important differential diagnosis in patients with lower limb claudication
M. Sigl, E. Hsu, H. Scheffel, S. Haneder, G. Rümenapf und K. Amendt (VASA 5/14)
Thromboangiitis obliterans (Buergers disease)
P.F. Klein-Weigel und J.G. Richter (VASA 5/14)
Cancer related venous thromboembolism - prophylaxis and incidence
T. Gary (VASA 4/14)
Venous thromboembolism and cancer pathophysiology and incidence
H. Striker (VASA 4/14)
MiRNAs in peripheral artery disease - something gripping this way comes
W. Kloss, B. Vogel, E. Blessing (VASA 3/14)
State-of-the-art aortic imaging: Part I - fundamentals and perspectives of CT an MRSI
F. Rengier, P. Geisbüsch, R. Vosshenrich, M. Müller-Eschner, C. Karmonik, P. Schoenhagen, H. von Tengg-Kobligk, S. Partovi (VASA 6/13)
Restenosis after infrapopliteal angioplasty - clinical importance, study update and further directions
F. Baumann, N. Diehm (VASA 6/13)
Livedoid vasculopathy - a thrombic disease
N. Kerk, T. George (VASA 5/13)
How to asses and improve cardiopulmonary risk prior to vascular surge?
A. Mahlmann, R.N. Rodionov, S. Ludwig, J. Neidel, N. Weiss (VASA 5/13)
Renal denervation - a clinical update and future directions
K. Mortensen, K. Franzen, M. Reppel, J. Weil (VASA 4/13)
Vascular accesses for hemodialysis - an update
C. Thalhammer, T. Pfammatter, S. Segerer (VASA 4/13)
Catheter-based treatment of ilio-femoral deep vein thrombosis - an update on current evidence
J. Fahrni, R.P. Engelberger, N. Kucher, T. Willenberg, I. Baumgartner (VASA 3/13)
Is aspirin still the drug of choice for management of patients with peripheral arterial disease? P. Poredos, M. K. Jezovnik (VASA 2/13)
May-Thurner Syndrom: Diagnose und Behandlung
N.F. Brazeau, H. B. Harvey, E. G. Pinto, A. Deipolyi, R. L. Hesketh, R. Oklu (VASA 2/13)
Influence of glucose metabolism on vascular smooth muscle cell proliferation
M. Chiong, P. E. Morales, G. Torres, T. Gutiérrez, L. García, M. Ibacache, L. Michea (VASA 1/13)
Novel applications of contrast-enhanced ultrasound imaging in vascular medicine D. Staub, S. Partovi, S. Imfeld, H. Uthoff, T. Baldi, M. Aschwanden, K. A. Jaeger (VASA 1/13)
Treatment of chronic wounds
H. Lawall (VASA 6/12)
Drug-eluting stents and perioperative risk - more than matters of the heart?
C. Lanckohr, G. Torsello, H. H. Scheld, B. Schieffer, G. Theimeier (VASA 6/12)
Current cencepts of the interventional treatment of proximal supraaortic vessel stenosis
U. Ernemann, B. Bender, A. Melms, K. Brechtel, J. Kobba, B. Balletshofer (VASA 5/12)
Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters
B. Linnemann, E. Lindhoff-Last (VASA 5/12)
Sclerotherapy in an undetected pregnancy - a catastrophe?
S. Reich-Schupke, A. Leiste, R. Moritz, P. Altmeyer, M. Stücker (VASA 4/12)
Drug-eluting stents and drug-coated balloons in peripheral artery disease
R. Buechel, A. Stirnimann, R. Zimmer, H. H. Keo, E. Groechenig (VASA 4/12)
Popliteal entrapment syndrome and age
M. Schweiter, R. Hügli, C. Koella, C. Jeanneret (VASA 4/12)
Novel oral anticoagulants - key messages for the angiologist
Sylvia Haas, Michael Spannagl, Sebastian Schellong (VASA 3/12)
Management of thoratic aortic lesions - the future is endovascular
R. Weidenhagen, René Bombien, Georgios, Meimarkis, Gerrit Geisler, Thomas Andreas Koeppel (VASA 3/12)
Health related quality of life in patients with critical limb ischemia - Lebensqualität bei Patienten mit kritischer Extremitätenischämie
H . Lawall, C. Zemmrich, P. Bramlage, B. Amann (VASA 2/12)
Drug-eluting stents for treatment of focal infrapopliteal lesions - Medikamenten-beschichtete Stents zur Behandlung fokaler Läsionen der Unterschenkelarterien
A. Rastan, E. Noory, T. Zeller (VASA 2/12)
Revascularization of carotid artery stenosis - a brief update on current evidence H.-C. Koennecke (VASA 1/12)
Duration if anticoagulation after venous thrombosis
S. Eichinger, P.A. Kyrle (VASA 1/12)
"Aspirin - resistance?" A few critical considerations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease and therapeutic consequences
R. Berent, H. Sinzinger (VASA 6/11)
Vascular anomalies in children
L. Weibel (VASA 6/11)
Varicose veins: A critical review of the definition and the therapeutical options - Varikosetherapie: Eine kritische Diskussion der Definition und der aktuellen Therapiemodalitäten
C. Jeanneret, K. Karatolios (VASA 5/11)
Results of open vascular surgical therapy in chronic peripheral arterial disease - Ergebnisse der konventionellen gefäßchirurgischen Therapie bei chronischer peripherer Verschlusserkrankung
K. M. Balzer, B. T. Weis-Müller (VASA 5/11)
Perioperative management and “Fast-Track” therapy in vascular medicine - Perioperatives Management und "Fast-Track" Therapie in der Gefäßmedizin
E. S. Debus, A. Ivoghli, M. Goepfert, T. Kölbel, A. Larena-Avellaneda (VASA 4/11)
Therapeutic arteriogenesis in peripheral arterial disease: combining intervention and passive training - Kombination von interventioneller Therapie und passivem Training
A. Bondke Persson, E.-E. Buschmann, R. Lindhorst, K. Troidl, R. Langhoff, K.-L. Schulte, I. Buschmann (VASA 3/11)
Multidisciplinary management of vascular access for haemodialysis: from the preparation of the initial access to the treatment of stenosis and thrombosis - Multidisziplinäres Management von Gefäßzugängen zur Hämodialyse
C. Reinhold, P. Haage, M. Hollenbeck, V. Mickley, J. Ranft (VASA 3/11)
Management of chronic atherosclerotic mesenteric ischemia - Behandlung der chronischen mesenterialen Ischämie
T. Zeller, R. Macharzina (VASA 2/11)
Systemic sclerosis - A systematic overview: Part 1 - Disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance / Systemische Sklerose - eine systematische Übersicht: Teil 1 - Krankheitscharakteristika und -klassifikation, pathophysiologische Konzepte und Empfehlungen zur Diagnostik und Verlaufskontrolle
P. Klein-Weigel, C. Opitz, G. Riemekasten (VASA 1/11)
Systemic sclerosis - A systematic overview: Part 2 - Immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension / Systemische Sklerose - eine systematische Übersicht: Teil 2 - Immunsupression, Behandlung der SSc-assoziierten Gefäßerkrankung und der Behandlung der pulmonalen arteriellen Hypertonie
C. Opitz, P. F. Klein-Weigel, G. Riemekasten (VASA 1/11)
New aspects of paradoxical embolism / Neue Aspekte der paradoxen Embolie
S. Lehmeyer, E. Lindhoff-Last (VASA 1/11)
Venous pressure gradients in the lower extremity and the hemodynamic consequences / Venöse Druckunterschiede in der unteren Extremität und ihre hämodynamischen Auswirkungen
C. Recek (VASA 4/10)
Treatment of acute aortic dissection type A (AADA): technical considerations / Behandlungsstrategien der akuten Aortendissektion Typ Stanford A
C. Hagl, N. Khaladj, S. Peterss, A. Bonz, M. Pichlmaier, A. Haverich, M. Shrestha (VASA 3/10)
Fabry disease - Vascular manifestations / Morbus Fabry - Vaskuläre Manifestationen
D. Karetova, J. Bultas, G. Dostalova, T. Palecek, T. Kovarnik, L. Golan, A. Linhart (VASA 2/10)
Aortic aneurysms after correction of aortic coarctation: A systemic review / Aortenaneurysmen nach Korrektur einer Coarctatio aortae: Eine systematische Literaturanalyse
Y. von Kodolitsch, A. M Aydin, A. M Bernhardt, C. Habermann, H. Treede, H. Reichenspurner, T. Meinertz, A. Dodge-Khatami (VASA 1/10)
Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: Do we need genetics for clinical decisions? / Marfan-Syndrom und das Spektrum angeborener thorakaler Aortenerkrankungen: Brauchen wir die Genetik, um klinische Entscheidungen zu treffen?
Y. von Kodolitsch, M. Rybczynski, A. Bernhardt, T. S Mir, H. Treede, A. Dodge-Khatami, P. N Robinson, S. Sheikhzadeh, H. Reichenspurner, T. Meinertz (VASA 1/10)
Cannabis-associated arteritis / Cannabis-assoziierte Arteritis
F. Grotenhermen (VASA 1/10)
Carotid artery stenting: A systematic review of randomized clinical trials / Carotid artery stenting (CAS): eine systematische Analyse randomisierter klinischer Studien
R. Knur (VASA 4/09)
New developments in tissue engineering of vascular prosthetic grafts / Tissue engineering: neue Entwicklungen zur Schaffung einer idealen Kunststoffprothese
T. Aper, A. Haverich, O. Teebken (VASA 2/09)
New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia
T. Zeller, S. Sixt, A. Rastan (VASA 1 /09)
New anticoagulants - towards the development of an "ideal" anticoagulant
S. Haas (VASA 1 /09)
Nephrogenic systemic fibrosis
R. Vosshenrich, P. Reimer (VASA 1 /09)
Traveller's thrombosis: International consensus statement / Die Reisethrombose: Stellungnahme der Internationalen Konsensuskonferenz W. Schobersberger, W. D. Toff, B. Eklöf, G. Fraedrich, H. C. Gunga, S. Haas, H. Landgraf, F. Lapostolle, H. Partsch, F. Perschler, J. Schapka, B. Schobersberger, J. H. Scurr, H. Watzke (VASA 4/08)
Studies on travel-related thrombosis / Studienlage zur Reisethrombose
P. Haas, H. Landgraf (VASA 4/08)
High-energy phosphate metabolism in the exercising muscle of patients with peripheral arterial disease / Stoffwechsel der energiereichen Phosphate unter Muskelbelastung bei Patienten mit peripherer arterieller Verschlusskrankheit
M. Schocke, R. Esterhammer, A. Greiner (VASA 4/08)
Assessment of generic and disease-specific health-related quality of life instruments in peripheral arterial disease / Die Erfassung der allgemeinen und gesundheitsbezogenen Lebensqualität bei Patienten mit peripherer arterieller Verschlusskrankheit - eine Übersicht
E. Knipfer, C. Reeps, C. Dolezal, A. Zimmermann, J. Pelisek, J. Behrens, H.-H. Eckstein (VASA 2/08)
Therapeutic angiogenesis for peripheral artery disease: Stem cell therapy / Therapeutische Angiogenese zur Behandlung der peripheren arteriellen Verschlusskrankheit: Stammzelltherapie
N. Lachmann, S. Nikol (VASA 4/07)
Therapeutic angiogenesis for peripheral artery disease: Cytokine therapy / Therapeutische Angiogenese zur Behandlung der peripheren arteriellen Verschlusskrankheit: Zytokintherapie
M. T. Kuhlmann, R. Klocke, S. Nikol (VASA 4/07)
Is atherosclerosis a mitochondrial disorder? / Ist die Atherosklerose eine mitochondriale Erkrankung?
J. Finsterer (VASA 4/07)
Therapeutic angiogenesis for peripheral artery disease - Gene therapy / Therapeutische Angiogenese zur Behandlung der arteriellen Verschlusskrankheit – Gentherapie
S. Nikol (VASA 3/07)